Filtering options
ADC
Advanced Analytics
Advanced Therapies
Annabel de Maria Memorial Scholarship Program
Antibody-Drug Conjugates
Autoimmune
Biologics
Biometrics
Biopharma
BioRegion
Biosimilars
Biostatistics
Biotech
Board of Directors
BTD
Cardiology
CDD
CDISC
CDMO
CDx
Cell & Gene Therapy (CGT)
Clinical
Clinical Operations
Clinical Trials
CMC
Co-Design
Companion Diagnostics
Complex Innovative Design
Contract Manufacturing
CRO
Crowdfunding
Data Science
Decentralized Clinical Trials
Dermatology
Diabetes
Digital Health
Digital Pathology
Digital Therapeutics
Digital Transformation
Diversity
Drug Delivery
Drug Development
Due Diligence
eCOA
Environmental Policy
Ethics
EU
European Medicines Agency
Evidence Generation
France
Funding
Genomic Testing
Global Payer Forum
Health Economics
Health Policy
Healthcare Technology
HEOR
Hospitals
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Infection Prevention
Innovation
Interview
Investor Relations
ISE/ISS
Italy
IVDR
Licensing
Life Sciences
Lifecycle Optimization
Lupus
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Myasthenia Gravis (MG)
Net-Present-Value Model
Neurology
Nuclear Medicine
Oncology
Orphan Drug
Orthopedic
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centricity
Patient Engagement
patient-centered
Patient-Enabled Innovation
Patient-Enabled Solutions
Pharma
Press Release
Pricing
Product Development
Radioligand Therapies (RLTs)
Radiopharmaceuticals
Radiotracer
Rare Disease
real-world evidence
Real-World Evidence (RWE)
Real-World Research
Registry
Registry-based studies
Regulatory
Research & Development
Research and Development
Responsible Growth
Robotic-Assisted Surgery (RAS)
RWE Decision Alert
SEND
Spain
Startups
Strategic Expansion
Sustainability
Therapeutics
Transaction Advisory
UK
us
USA
Vaccines
Value-Based Contracts
Wound Healing
All
Scientific Articles
Latest from Alira Health
Patient Preference Studies: Patient Experience as Decision-Grade Evidence
Discover how patient preference studies use qualitative and quantitative methods to generate decision-Grade Evidence across development and commercialization.
FDA Initiatives and Programs to Support Development of Treatments for Rare Diseases in 2026
Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Small Biotech Company With Complex, Innovative Cell Immunotherapy in Oncology Executes Successful Phase Ib Clinical Trial Across Multiple Sites
Discover how a biotech company executed a complex Phase I trial with Alira Health, ensuring seamless coordination of manufacturing, logistics, and sites.
European Biotech Company Implements a Quality Management System Tailored for Agile SaaS Development
Discover how a biotech SaaS company implemented an ISO 13485 and IEC 62304 compliant QMS tailored to an agile development.
2026 Joint Statistical Meetings
Meet us at booth 610 and learn how we help our clients to navigate complex challenges across the clinical trial landscape.
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
BioJapan 2026
Join us at BioJapan 2026 and discover how we support Japanese life sciences companies bring their innovations to global markets.
AXIS Registry Enrolls Its First 100 People Living with Myasthenia Gravis
The AXIS Registry enrolls its first 100 participants living with myasthenia gravis, a key milestone advancing patient-centered research in autoimmune neurological diseases.
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
Alira Health Establishes Annabel de Maria Memorial Scholarship to Inspire the Next Generation of Healthcare Leaders
Alira Health today announced the Annabel de Maria Memorial Scholarship Program, an annual initiative created to continue the legacy of Annabel de Maria, who served as the company's(...)
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
The 2026 Biologics Contract Manufacturing Report
Discover the latest biologics CDMO market insights on manufacturing, investment, and M&A trends shaping the industry. Access the 2026 report today.
Nuclear Medicine in 2026: How Market Access Determines Lifecycle Success
Discover how nuclear medicine market access shapes lifecycle success in 2026 and what leaders must do to align strategy, evidence, and delivery.
Cross-Border Access to Rare Disease Clinical Trials: A Patient-Centric Approach to Feasibility and Execution
Watch the webinar to get practical insights on cross-border rare disease clinical trials and explore patient-centric strategies that support sponsor execution and patient access.
Global Payer Forum 2026
Educational webinar series about Value-Based Contracting by payers and academic experts and covering VBC fundamentals to success assessment.
Most Favored Nation: US Implementation and European Implications
This webinar explores how MFN pricing may impact US drug prices, access in Europe, launch strategies, and biotech investment.
Subscribe to our newsletter for the latest news, events, and thought leadership